77 related articles for article (PubMed ID: 20592646)
21. Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects.
Johnson BA; O'Malley SS; Ciraulo DA; Roache JD; Chambers RA; Sarid-Segal O; Couper D
J Clin Psychopharmacol; 2003 Jun; 23(3):281-93. PubMed ID: 12826990
[TBL] [Abstract][Full Text] [Related]
22. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence.
Boeijinga PH; Parot P; Soufflet L; Landron F; Danel T; Gendre I; Muzet M; Demazières A; Luthringer R
Neuropsychobiology; 2004; 50(1):71-7. PubMed ID: 15179024
[TBL] [Abstract][Full Text] [Related]
25. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
Nunes T; Machado R; Rocha JF; Fernandes-Lopes C; Costa R; Torrão L; Loureiro AI; Falcão A; Vaz-da-Silva M; Wright L; Almeida L; Soares-da-Silva P
Clin Ther; 2009 Oct; 31(10):2258-71. PubMed ID: 19922897
[TBL] [Abstract][Full Text] [Related]
27. Acamprosate and primitive reflexes.
Guzik P; Bankes L; Brown TM
Ann Pharmacother; 2007 Apr; 41(4):715-8. PubMed ID: 17389668
[TBL] [Abstract][Full Text] [Related]
28. Quantification of sofalcone in human plasma and urine by high performance liquid chromatography-mass spectrometry.
Wang L; Song L; Jiang X
J Pharm Biomed Anal; 2011 Jul; 55(5):1179-85. PubMed ID: 21530127
[TBL] [Abstract][Full Text] [Related]
29. Determination of the transdermal bioavailability of a newly developed diclofenac sodium patch in comparison with a reference preparation.
Gschwend MH; Martin W; Arnold P; Verdun MO; Cambon N; Frentzel A; Scheiwe W
Arzneimittelforschung; 2005; 55(7):403-13. PubMed ID: 16080280
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the relationship between in vitro and in vivo release behaviors of acamprosate from enteric-coated tablets.
Rhee YS; Park S; Lee TW; Park CW; Nam TY; Oh TO; Jeon JW; Lee DS; Park ES
Arch Pharm Res; 2008 Jun; 31(6):798-804. PubMed ID: 18563364
[TBL] [Abstract][Full Text] [Related]
31. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
32. Establishment of a liquid chromatographic/mass spectrometry method for quantification of tetrandrine in rat plasma and its application to pharmacokinetic study.
Song N; Zhang S; Li Q; Liu C
J Pharm Biomed Anal; 2008 Nov; 48(3):974-9. PubMed ID: 18650047
[TBL] [Abstract][Full Text] [Related]
33. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
34. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
[TBL] [Abstract][Full Text] [Related]
35. The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin.
Hammarberg A; Nylander I; Zhou Q; Jayaram-Lindström N; Reid MS; Franck J
Brain Res; 2009 Dec; 1305 Suppl():S2-6. PubMed ID: 19799882
[TBL] [Abstract][Full Text] [Related]
36. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
Mason BJ; Goodman AM; Chabac S; Lehert P
J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
[TBL] [Abstract][Full Text] [Related]
37. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
[TBL] [Abstract][Full Text] [Related]
38. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
Wölwer W; Frommann N; Jänner M; Franke PE; Scherbaum N; Lieb B; Falkai P; Wobrock T; Kuhlmann T; Radermacher M; Maier W; Schütz C; Ohmann C; Burtscheidt W; Gaebel W
Drug Alcohol Depend; 2011 Nov; 118(2-3):417-22. PubMed ID: 21621929
[TBL] [Abstract][Full Text] [Related]
39. Development of an ultra-performance liquid chromatography technique coupled with mass spectrometry for the measurement of tacrolimus in micro-samples of whole blood, and its application on a pharmacokiinetic trial.
Marcelín-Jiménez G; García-González A; Angeles-Moreno AP; Contreras-Zavala L; Rivera L; Morales M
Arzneimittelforschung; 2007; 57(10):659-64. PubMed ID: 18074760
[TBL] [Abstract][Full Text] [Related]
40. Kinetic study of acamprosate absorption in rat small intestine.
Más-Serrano P; Granero L; Martín-Algarra RV; Guerri C; Polache A
Alcohol Alcohol; 2000; 35(4):324-30. PubMed ID: 10905995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
